Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Nurix Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get NRIX alerts

About Christine Ring

Christine Ring is recorded as General Counsel at Nurix Therapeutics, Inc. (NRIX). The newest filing on record that lists Christine Ring as General Counsel at Nurix Therapeutics, Inc. (NRIX) is dated March 24, 2023. The proxy statement of Nurix Therapeutics, Inc. reports total compensation of $2,263,337 for Christine Ring in fiscal 2025, including a base salary of $527,500. Disclosed compensation is on record for 4 fiscal years. Nurix Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nurix Therapeutics, Inc. includes Arthur T. Sands (CEO and Board Member), Hans van Houte (CFO), Stefani Wolff (COO) and 7 others.

Affiliation history

Company network

Leadership on record at Nurix Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Nurix Therapeutics, Inc. (NRIX) $527,500 $2,263,337
2024 Nurix Therapeutics, Inc. (NRIX) $498,677 $2,016,484
2021 Nurix Therapeutics, Inc. (NRIX) $413,750 $1,648,895
2020 Nurix Therapeutics, Inc. (NRIX) $376,250 $1,307,091

Recent activity

No call appearances or filed executive changes recorded yet.